{
    "doi": "https://doi.org/10.1182/blood.V104.11.3211.3211",
    "article_title": "Geographic and Racial/Ethnic Differences in HFE Mutation Frequencies and Iron Phenotypes in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. ",
    "article_date": "November 16, 2004",
    "session_type": "Poster Sessions",
    "abstract_text": "Designing an optimal screening approach for hemochromatosis and iron overload requires knowledge of racial/ethnic subpopulations and frequencies of HFE mutations and phenotypes in geographic areas. In the HEIRS Study, HFE C282Y and H63D genotypes and prevalences of participants who met biochemical criteria for further evaluation (transferrin saturation >50% and ferritin >300 ng/mL, men; >45% and >200 ng/mL, women) were compared in a primary care-based sample of ~100,000 adults \u226525 years from 5 Field Centers. There were different respective HFE C282Y and H63D genotype frequencies in Whites, Blacks, Asians, and Hispanics across geographic areas (all p<0.0001), but not in Native Americans or Pacific Islanders. In Whites, the C282Y/C282Y proportion was significantly higher in AL than in CA or OR/HI. AL also had a significantly higher proportion of C282Y/wt than CA or OR/HI. In Blacks, D.C. had a significantly higher proportion of C282Y and H63D genotypes than AL. ONT had a significantly higher H63D genotype proportion than AL. In Asians, CA had a significantly higher proportion of H63D genotypes than OR/HI or ONT. In Hispanics, there were significant differences between: AL and CA; AL and D.C.; CA and D.C.; CA and OR/HI; D.C. and OR/HI; and D.C. and ONT. We also observed: Prevalences of Participants Who Met Biochemical Criteria for Further Evaluation  Race/Ethnicity . Geographic Area . Prevalence (%) . 95% CI . Asians California 5.54 4.98, 6.16  Oregon/Hawaii 5.06 4.29, 5.95  Ontario 4.25 3.69, 4.88  Alabama 1.41 0.25, 7.56  D.C. 0.96 0.26, 3.42 Pacific Islanders California 3.66 1.25, 10.21  Oregon/Hawaii 3.47 2.23, 5.36 Native Americans Alabama 2.65 0.91, 7.52  Oregon/Hawaii 2.50 0.69, 8.66  D.C. 0.99 0.17, 5.40  Ontario 0.75 0.21, 2.71 Whites Ontario 2.31 2.08, 2.56  California 1.93 1.56, 2.37  Oregon/Hawaii 1.52 1.34, 1.73  Alabama 1.48 1.26, 1.74  D.C. 1.40 0.80, 2.43 Hispanics Ontario 1.92 0.82, 4.41  California 1.52 1.28, 1.79  Oregon/Hawaii 1.34 0.73, 2.4  Alabama 0.84 0.23, 3.01  D.C. 0.74 0.48, 1.16 Blacks D.C. 1.75 1.56, 1.96  Ontario 1.55 0.52, 4.45  Alabama 1.09 0.90, 1.32  Oregon/Hawaii 0.92 0.31, 2.66  California 0.86 0.29, 2.51 Race/Ethnicity . Geographic Area . Prevalence (%) . 95% CI . Asians California 5.54 4.98, 6.16  Oregon/Hawaii 5.06 4.29, 5.95  Ontario 4.25 3.69, 4.88  Alabama 1.41 0.25, 7.56  D.C. 0.96 0.26, 3.42 Pacific Islanders California 3.66 1.25, 10.21  Oregon/Hawaii 3.47 2.23, 5.36 Native Americans Alabama 2.65 0.91, 7.52  Oregon/Hawaii 2.50 0.69, 8.66  D.C. 0.99 0.17, 5.40  Ontario 0.75 0.21, 2.71 Whites Ontario 2.31 2.08, 2.56  California 1.93 1.56, 2.37  Oregon/Hawaii 1.52 1.34, 1.73  Alabama 1.48 1.26, 1.74  D.C. 1.40 0.80, 2.43 Hispanics Ontario 1.92 0.82, 4.41  California 1.52 1.28, 1.79  Oregon/Hawaii 1.34 0.73, 2.4  Alabama 0.84 0.23, 3.01  D.C. 0.74 0.48, 1.16 Blacks D.C. 1.75 1.56, 1.96  Ontario 1.55 0.52, 4.45  Alabama 1.09 0.90, 1.32  Oregon/Hawaii 0.92 0.31, 2.66  California 0.86 0.29, 2.51 View Large The percentage of men who met biochemical criteria for further evaluation was greater than that of women. We conclude that 1) C282Y and H63D genotype frequencies vary significantly within a single racial/ethnic group across geographic regions; and 2) the percentage of participants who met biochemical criteria for further evaluation varies by racial/ethnic group.",
    "topics": [
        "hemochromatosis",
        "iron",
        "iron overload",
        "mutation",
        "phenotype",
        "screening",
        "ferritin",
        "transferrin saturation measurement",
        "ethnic differences",
        "hawaii"
    ],
    "author_names": [
        "Ronald T. Acton, Ph.D.",
        "Beverly M. Snively, Ph.D.",
        "James C. Barton, M.D.",
        "Paul C. Adams, M.D.",
        "John H. Eckfeldt, M.D., Ph.D.",
        "Emily L. Harris, Ph.D.",
        "Fitzroy W. Dawkins, M.D.",
        "Christine E. McLaren, Ph.D.",
        "Victor R. Gordeuk, M.D.",
        "Gordon D. McLaren, M.D.",
        "David M. Reboussin, Ph.D.",
        "Phyliss Sholinsky, M.S.P.H",
        "Mark R. Speechley, Ph.D.",
        "Joan Holup, M.A.",
        "Cathy Leiendecker-Foster, M.S."
    ],
    "author_dict_list": [
        {
            "author_name": "Ronald T. Acton, Ph.D.",
            "author_affiliations": [
                "Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Beverly M. Snively, Ph.D.",
            "author_affiliations": [
                "Public Health Sciences, Wake Forest University, Winston-Salem, NC, USA"
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "James C. Barton, M.D.",
            "author_affiliations": [
                "Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Paul C. Adams, M.D.",
            "author_affiliations": [
                "Medicine, London Health Sciences Center, London, ON, Canada"
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "John H. Eckfeldt, M.D., Ph.D.",
            "author_affiliations": [
                "Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Emily L. Harris, Ph.D.",
            "author_affiliations": [
                "Center for Health Research, Kaiser Permanente, Portland, OR, USA"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Fitzroy W. Dawkins, M.D.",
            "author_affiliations": [
                "Medicine, Howard University, Washington, DC, USA"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Christine E. McLaren, Ph.D.",
            "author_affiliations": [
                "Medicine, University of California, Irvine, CA, USA"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Victor R. Gordeuk, M.D.",
            "author_affiliations": [
                "Medicine, Howard University, Washington, DC, USA"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gordon D. McLaren, M.D.",
            "author_affiliations": [
                "Medicine, VA Long Beach Healthcare System, Long Beach, CA, USA"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "David M. Reboussin, Ph.D.",
            "author_affiliations": [
                "Public Health Sciences, Wake Forest University, Winston-Salem, NC, USA"
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Phyliss Sholinsky, M.S.P.H",
            "author_affiliations": [
                "Genetic Epidemiology, National Heart, Lung and Blood Institute, Bethesda, MD, USA"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mark R. Speechley, Ph.D.",
            "author_affiliations": [
                "Medicine, London Health Sciences Center, London, ON, Canada"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Joan Holup, M.A.",
            "author_affiliations": [
                "Center for Health Research, Kaiser Permanente, Honolulu, HI, USA"
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Cathy Leiendecker-Foster, M.S.",
            "author_affiliations": [
                "Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA"
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-04-24T03:41:53",
    "is_scraped": "1"
}